Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

High Dividend Dow Stocks

Investors are concerned about a Lehman-like collapse in Europe and are spooked by the S&P’s downgrade of America’s credit rating. DJIA went down by 5.6% and the S&P 500 index lost 6.7%. It isn’t a surprise that the S&P 500 index underperformed the DJIA during this downturn. The constituents of DJIA are larger, more stable companies with larger dividend payments. High dividend stocks perform better than other stocks in the long-run.

We also prefer high dividend stocks over long-term treasuries. The 10-year treasury bond has a 2.3% yield to maturity at this moment. The bonds are performing spectacularly in this down market, but over the next 10 years they aren’t good investments. An investor who bets $100 on a high dividend stock that yields more than 5% will perform better than the 10-year treasury holders if the high dividend stock doesn’t go down more than 25% over the next 10 years. We don’t think that’s very likely for a diversified portfolio of high dividend yielding stocks. That’s why we like high dividend stocks.

The 15 Dow components with the highest dividend yield outperformed the market by nearly 6 percentage points this year. See the complete list of these stocks here.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!